the differences in cytolysis and growth inhibition of neoplastic hematopoietic cells and hematopoietic progenitor cells by lak cells in vitro could create a therapeutic index that might allow the use of lak cells for cleansing of the autologous bone marrow graft and for adjuvant therapy in combination with autologous bone marrow transplantation without compromising the reconstitution of the bone marrow in the host .
C0018957
hematopoietic
C0005953
bone marrow